Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Marts 2024

Genmab — Marts 2024

Planlagt Fastgjort Låst Flyttet Genmab
830 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • L Offline
    L Offline
    lahn1
    wrote on sidst redigeret af
    #129

    Tror ikke vi er der, hvor det generelle markede vil se en udskiftning af Jan som en positiv nyhed. Under alle omstændigheder vil det skabe ydereligere usikkerhed.

    1 Reply Last reply
    0
    • E Offline
      E Offline
      E_L
      wrote on sidst redigeret af
      #130

      Epcoritamab, a Promising Therapy for Richter Syndrome? https://www.hematologyandoncology.net/archives/march-2024/epcoritamab-a-promising-therapy-for-richter-syndrome/

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #131

        AACR Annual Meeting 2024 Abstract titles via
        https://www.abstractsonline.com/pp8/#!/20272/presentations/epcoritamab/1

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #132

          the Inclacumab trial still going and seems fully recruited. Primary Completion this summer. I had a very low probability on this
          , but who knows... https://classic.clinicaltrials.gov/ct2/history/NCT04935879?B=11&A=10&C=merged#StudyPageTop

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #133

            HC Wainwright restated a "buy" rating and issued a $50.00 price target on shares of Genmab A/S in a report on Wednesday.

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #134

              Johnson & Johnson submits application to the European Medicines Agency for DARZALEX® (daratumumab)-based quadruplet therapy for the treatment of patients with transplant-eligible, newly diagnosed multiple myeloma / PERSEUS https://www.globenewswire.com/news-release/2024/03/06/2841454/0/en/Johnson-Johnson-submits-application-to-the-European-Medicines-Agency-for-DARZALEX-daratumumab-based-quadruplet-therapy-for-the-treatment-of-patients-with-transplant-eligible-newly-.html

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #135

                Daratumumab in Pediatric Heart Transplantation. https://twitter.com/PHTSociety/status/1765385728102404100/photo/1

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  lahn1
                  wrote on sidst redigeret af
                  #136

                  Tak EL !

                  1 Reply Last reply
                  0
                  • troldmandenT Offline
                    troldmandenT Offline
                    troldmanden
                    wrote on sidst redigeret af
                    #137

                    Novo har lige fremhævet Mim8. At det er en prioritet at maximize Mim8 muligheden

                    1 Reply Last reply
                    0
                    • R Offline
                      R Offline
                      Riis7
                      wrote on sidst redigeret af
                      #138

                      Genmab skal ha det Novo tager;-)

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #139

                        https://www.morningstar.com/company-reports/1211878-genmab-strong-royalty-revenue-from-darzalex-provides-ample-cash-flow-shares-undervalued?listing=0P0000A5QU morningstar maintains fair value target of 2650

                        1 Reply Last reply
                        0
                        • P Offline
                          P Offline
                          peter12
                          wrote on sidst redigeret af
                          #140

                          Nu skal der sælges epo https://www.roi-nj.com/2024/03/07/healthcare/genmab-promising-to-add-300-jobs-to-2nd-location-in-plainsboro-gets-8-4m-emerge-tax-credit/

                          1 Reply Last reply
                          0
                          • K Offline
                            K Offline
                            kkjoel
                            wrote on sidst redigeret af
                            #141

                            Stærkt fund, Peter
                            🙂

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bikube
                              wrote on sidst redigeret af
                              #142

                              Er det ikke EPCO, du mener peter?

                              1 Reply Last reply
                              0
                              • P Offline
                                P Offline
                                peter12
                                wrote on sidst redigeret af
                                #143

                                Nå jo der kan man c 😉

                                1 Reply Last reply
                                0
                                • P Offline
                                  P Offline
                                  peter12
                                  wrote on sidst redigeret af
                                  #144

                                  Det må være i tilknytning til deres nuværende lokation i NJ https://www.colliers.com/en/properties/class-a-building-in-corporate-campus-setting/usa-777-scudders-mill-road-plainsboro-new-jersey-08536/usa1037869

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #145

                                    https://www.novonordisk.com/content/dam/nncorp/global/en/investors/pdfs/capital-markets-day-2022/P6-rare-disease.pdf follwoing troldmanden comment this morning, Novo capital-markets-day rare-disease presentation

                                    1 Reply Last reply
                                    0
                                    • B Offline
                                      B Offline
                                      Brit
                                      wrote on sidst redigeret af
                                      #146

                                      @EL skulle det ikke have været i Novo chatten?

                                      1 Reply Last reply
                                      0
                                      • BulderB Offline
                                        BulderB Offline
                                        Bulder
                                        wrote on sidst redigeret af
                                        #147

                                        Nej, det handler om mim8, som er et antistof, som Genmab får royalties fra.

                                        1 Reply Last reply
                                        0
                                        • B Offline
                                          B Offline
                                          Brit
                                          wrote on sidst redigeret af
                                          #148

                                          Åhh, der var jeg ikke opmærksom, Bulder

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper